| Patients, n | ≥120 mg OME | ≥120 mg OME for chronic pain | Drugs dose frequency | Indication | Overuse/misuse | Medication review last 3 months | Co-prescribing z drugs | Co-prescribing benzdiazepines | Co-prescribing gaba drugs | Gabapentin >3.6 g | Pregabalin >600 mg | Reflection |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 663 418 | 1022 (0.15% on high-dose opioids) | 894 (0.13% on high-dose opioids for chronic pain;(894/1022 = 87.5% on high-dose for of chronic pain) | 861 (96.3% clear) | 593 (In 593/861 patients the indications is clear =68.9%; 31.1% not clear) | 61 (61/894 = 6.8%) | 429 (429/894 = 48.0%) | 119 (119/894 =13.3%) | 126 (126/894 = 14.1%) | 379 (379/894 co-prescribed gaba drugs = 42.4%) | 5 (5/894 on >3.6 g per day = 0.6%) | 11 (11/894 on >600 mg pregabalin per day = 1.2%) | 59 (59/74=80%) |
OME = oral morphine equivalent.